Key takeaways:
Pimobendan (Vetmedin) is an FDA-approved prescription medicine to manage heart failure in dogs with dilated cardiomyopathy or myxomatous mitral valve disease.
Pimobendan works by increasing the heart muscle’s ability to contract and by dilating peripheral blood vessels. This makes it easier for the heart to pump blood effectively.
Pimobendan is generally well tolerated by most dogs, can be used with other heart medications, and has a very low risk of side effects.
Heart failure is a disease commonly diagnosed in older, smaller-breed dogs. It causes symptoms such as coughing and the inability to exercise. And it negatively impacts the quality of life and lifespan for dogs diagnosed with the condition.
The good news is that now there are safe, effective medications including pimobendan (Vetmedin) for dogs. Pimobendan can minimize symptoms and slow the progression of congestive heart failure.
In this article, you will learn what pimobendan is, how it works, its potential side effects, and what to do if you miss giving your dog a dose.
Common names | Pimobendan (Vetmedin) |
What it treats | Heart failure due to myxomatous mitral valve disease or dilated cardiomyopathy |
How it comes (forms) | Tablet, chewable tablet, oral liquid, capsule |
Dosage | Depends on a dog’s weight |
Common side effects | Poor appetite, lethargy, loose stool, vomiting |
Average cost |
Pimobendan is a benzimidazole-pyridazinone derivative medication. It improves how well the heart muscles contract and lowers blood pressure by dilating peripheral blood vessels.
Pimobendan is FDA-approved for dogs with congestive heart failure due to myxomatous mitral valve disease or dilated cardiomyopathy.
Myxomatous mitral valve disease (MMVD) causes the mitral valve in the heart’s left ventricle to decline. This causes blood to leak backward when the heart muscles squeeze. MMVD accounts for about 75% of all heart disease in dogs. Small- and medium-sized dog breeds are at highest risk for MMVD.
Dilated cardiomyopathy (DCM) is a disease of the heart muscles themselves. It causes a weakened heart that cannot effectively pump blood.
Both MMVD and DCM eventually lead to congestive heart failure, which causes:
Heart disease treatments: Heart disease is common in dogs, and there are a number of options to treat it. Learn the best ways to help your pup’s heart.
Dog heart murmur: A heart murmur can be an early sign of heart disease in dogs. Here’s what you need to know if your veterinarian diagnoses a heart murmur in your pup.
GoodRx for Pets: Did you know you may be able to save money on your pet’s prescriptions using GoodRx? This article tells you how.
Neither of these heart diseases are curable. But pimobendan is a medication that can help manage the symptoms of heart failure in dogs. As a result, your pup will have fewer heart-related symptoms, and their lifespan may be increased.
Pimobendan is also available in a new formulation that is conditionally FDA-approved called Vetmedin-CA1. It’s designed to slow the progression of mitral valve disease and delay the onset of heart failure in dogs.
Pimobendan is available for dogs by prescription from a veterinarian. It comes in the following forms:
Chewable flavored tablet
Tablet
Capsule
Flavored oral liquid
The typical dosage of pimobendan for dogs is 0.25 mg to 0.3 mg per kilogram of body weight. Your veterinarian will determine the correct dosage for your dog. The medication is given in two doses 12 hours apart.
The medication can be crushed to make it easier to give to your dog. It can be given with or without food.
If you miss giving your dog a dose of pimobendan, give them the next dose as soon as you remember. Then resume their regular dosing schedule.
If it is close to the time of your dog’s next dose, skip the missed dose. Then give the next dose at the regular time.
Never give two doses at the same time to make up for a missed dose. If you have any questions or feel concerned, contact your veterinarian for advice.
Dogs taking pimobendan may experience the following side effects:
Lack of energy
In general, pimobendan appears to be safe and well tolerated by most dogs. Adverse effects are relatively rare and are mostly related to gastrointestinal upset.
Some serious risks have been reported in dogs taking pimobendan. These risks include:
Shortness of breath
Weakness
Wobbly gait
Too much waste circulating in the blood
Fluid in the lungs or abdomen
Fainting
Cough
Sudden death
Some of these reported risks are also symptoms of heart failure. So some of these serious symptoms may be related to the progression of a dog’s heart disease rather than the medication itself.
Pimobendan should not be used, or should be used with extreme caution, in dogs with congestive heart failure due to an outflow obstruction. This includes dogs diagnosed with:
Subaortic stenosis
Pulmonic stenosis
Systolic anterior motion of the mitral valve
Asymmetric septal hypertrophy
Pericardial effusion
The safety of pimobendan has not been tested in dogs younger than 6 months old.
Pimobendan generally does not interact with other dog medications. It can be safely given with other heart medications, including diuretics, ace inhibitors, and digoxin.
Using pimobendan at the same time as a beta blocker or calcium channel blocker may prevent pimobendan from working as well as it should. It’s usually not recommended for dogs taking these medications. Examples of beta and calcium channel blockers include:
Propranolol
Atenolol
Verapamil
Before your dog is prescribed pimobendan, make sure your veterinarian is aware of any other medications and supplements your dog takes.
Pimobendan (Vetmedin) is a medication used to delay the start of heart failure symptoms in dogs with dilated cardiomyopathy or mitral valve disease. It also helps manage the symptoms of heart failure. Pimobendan works by increasing how well the heart muscle contracts and by dilating blood vessels. This helps the heart pump blood more effectively. Pimobendan is generally well tolerated by most dogs, with a low risk of negative side effects. It’s an excellent tool for treating some dogs with heart failure, and it can increase how long dogs in heart failure live.
Boehringer Ingelheim. (2023). Vetmedin (pimobendan) chewable tablets [package insert].
Boehringer Ingelheim. (2023). Vetmedin-CA1 (pimobendan) chewable tablets [package insert].
Fuentes, V. L. (2005). Use of pimobendan in the management of heart failure. Veterinary Clinics of North America: Small Animal Practice.
Kittleson, M. D. (2018). Heart failure in dogs. Merck Veterinary Manual.
Parker, H. G., et al. (2012). Myxomatous mitral valve disease in dogs: Does size matter? Journal of Veterinary Cardiology.
Prošek, R. (2023). Dilated cardiomyopathy in dogs and cats. Veterinary Partner.
Rishniw, M. (2019). Pimobendan (Vetmedin). Veterinary Partner.
Rishniw, M. (2024). Mitral valve disease in dogs and cats. Veterinary Partner.
Rush, J. E. (2002). Chronic valvular heart disease in dogs. Waltham Diets/OSU Symposium, Small Animal Cardiology.
Saunders, A. B., et al. (2018). Pimobendan and heart disease. Today’s Veterinary Practice.
U.S. Food and Drug Administration. (2024). FDA approves first generic pimobendan for management of congestive heart failure in dogs.
Veterinary Information Network. (2022). Pimobendan.